Home
About
Overview
Sharing Data
ORCID
Help
History (56)
A randomized, double-blind, placebo-controlled trial of CDP571, a humanized monoclonal antibody to tumour necrosis factor-alpha, in patients with corticosteroid-dependent Crohn's disease.
Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer.
Mycobacterial infection induces a specific human innate immune response.
Aberrometry
Multicohort Retrospective Validation of a Predictive Biomarker for Topoisomerase I Inhibitors.
See All 56 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Multicohort Retrospective Validation of a Predictive Biomarker for Topoisomerase I Inhibitors.
Multicohort Retrospective Validation of a Predictive Biomarker for Topoisomerase I Inhibitors. Clin Colorectal Cancer. 2021 06; 20(2):e129-e138.
View in:
PubMed
subject areas
Antineoplastic Agents
Biomarkers, Tumor
Colorectal Neoplasms
DNA Topoisomerases, Type I
Humans
Male
Middle Aged
Pancreatic Neoplasms
Retrospective Studies
Risk Assessment
Stomach Neoplasms
authors with profiles
Ravi Salgia